2Seventy Bio Inc (TSVT) — Strategic Asset Allocation Index
2Seventy Bio Inc (TSVT) has a Strategic Asset Allocation Index of 1.4% as of March 2025. Strategic assets (PP&E of $- plus long-term investments of $2.99 Million) total $2.99 Million, measured against net assets of $213.96 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
2Seventy Bio Inc Strategic Asset Allocation Index (2019–2024)
This chart shows how 2Seventy Bio Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2019 to 2024. As of March 2025, the index stands at 1.4%, representing strategic assets of $2.99 Million against net assets of $213.96 Million USD. Explore 2Seventy Bio Inc (TSVT) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for 2Seventy Bio Inc (2019–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for 2Seventy Bio Inc from 2019 to 2024, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 2Seventy Bio Inc (TSVT) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 4.2% | $8.87 Million | $- | $8.87 Million | $210.81 Million | ▲ +2.3 pp |
| 2023 | 1.9% | $4.82 Million | $- | $4.82 Million | $255.30 Million | ▼ -16.5 pp |
| 2022 | 18.4% | $57.15 Million | $55.73 Million | $1.41 Million | $310.47 Million | ▼ -18.3 pp |
| 2021 | 36.7% | $132.04 Million | $34.91 Million | $97.12 Million | $359.82 Million | ▼ -312.3 pp |
| 2020 | 349.0% | $260.48 Million | $260.48 Million | $0.00 | $74.63 Million | ▼ -240.4 pp |
| 2019 | 589.4% | $257.52 Million | $257.52 Million | $- | $43.69 Million | — |